Nantahala Capital Management »

Anebulo Pharmaceuticals shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Anebulo Pharmaceuticals (ANEB) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Anebulo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Anebulo Pharmaceuticals held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anebulo Pharmaceuticals by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 511k 2.42
2023-09-30 $1.6M 511k 3.06
2023-06-30 $1.2M 511k 2.35
2023-03-31 $1.5M 511k 2.90
2022-12-31 $1.2M 511k 2.42
2022-09-30 $1.4M 511k 2.80

More positions owned by Nantahala Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Meta Financial (CASH)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Costco Wholesale Corporation Put Option (COST)
Imax Corp Cad (IMAX)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)

View all positions for Nantahala Capital Management

Top funds holding Anebulo Pharmaceuticals

22NW
LVW Advisors
Nantahala Capital Management
Ikarian Capital
Vanguard Group
Landscape Capital Management
ADAR1 Capital Management
Royal Bank of Canada
Wells Fargo & Company
Bank of America Corporation

View all funds holding Anebulo Pharmaceuticals